Metropolitan Life Insurance Company (MetLife)’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-9,153
| Closed | -$77.9K | – | 2855 |
|
|
2021
Q3 | $77.9K | Hold |
9,153
| – | – | ﹤0.01% | 2652 |
|
|
2021
Q2 | $150K | Buy |
9,153
+1,195
| +15% | +$19.6K | ﹤0.01% | 2362 |
|
|
2021
Q1 | $176K | Hold |
7,958
| – | – | ﹤0.01% | 2113 |
|
|
2020
Q4 | $246K | Hold |
7,958
| – | – | ﹤0.01% | 1801 |
|
|
2020
Q3 | $162K | Buy |
7,958
+2,288
| +40% | +$46.5K | ﹤0.01% | 1916 |
|
|
2020
Q2 | $87.1K | Buy |
+5,670
| New | +$87.1K | ﹤0.01% | 2339 |
|